UNH vs VRTX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | VRTX |
|---|---|---|
| Price | $396.59 | $552.85 |
| Market cap | $355.98B | $140.13B |
| P/E ratio | 25.6 | 31.8 |
| ROE | 14.15% | 23.54% |
| Profit margin | 3.14% | 35.00% |
| Revenue growth | 0.40% | 12.50% |
| Dividend yield | 2.33% | — |
| Beta | 0.63 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs VRTX in plain English
- UNH is the bigger company — about 2.5× the market cap of VRTX.
- UNH is cheaper on earnings (P/E 25.6 vs 31.8).
- VRTX earns a higher return on equity (24% vs 14%).
- VRTX is growing revenue faster (12% vs 0%).
- UNH pays a dividend (2.33%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.